Videos

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side effects of breast cancer treatment.

CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.

Panelists discuss how implementing targeted strategies can promote equity in treatment for all patients, while offering practical advice for those facing barriers to accessing necessary care for advanced prostate cancer.

Panelists discuss how personal experiences with access- to- care challenges highlight the need for systemic improvements and proactive solutions to ensure that all patients with advanced prostate cancer receive timely and effective treatment.

CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during breast cancer treatment.

In this on-demand webinar series, CURE partnered with City of Hope to discuss how patients with breast cancer can best communicate with their care team.

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment decisions for breast cancer.

Panelists discuss how the diagnosis and treatment of advanced prostate cancer can significantly impact intimacy and relationships, emphasizing the importance of open communication about goals and preferences in treatment decisions, while also sharing strategies for self-advocacy and maintaining quality of life (QOL) throughout the treatment journey.

Panelists discuss how various support groups and resources for patients with advanced prostate cancer can provide essential guidance and community, while sharing personal experiences on finding and using these valuable tools throughout their treatment journey.

An expert explained how sentinel lymph node biopsy has helped surgeons remove fewer lymph nodes, which can reduce lymphedema risk in patients with breast cancer.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.

CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center for a webinar to discuss the importance of self-advocacy.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.

An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.

An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”

Panelists discuss how a comprehensive treatment approach for advanced prostate cancer involves considering various patient-specific factors, the transformative role of androgen receptor pathway inhibitors (ARPIs), and the necessity of early and aggressive intervention, while emphasizing the importance of clear communication between oncologists and patients regarding treatment expectations and options.

Panelists discuss how assessing patients' responses to treatment and addressing common adverse effects are essential for effective management of advanced prostate cancer, while also highlighting the importance of patient education and preparation before starting therapy.

An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.

Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.

Patients undergoing transoral robotic surgery or radiation for oropharyngeal cancer should try to eat during treatment to maintain swallowing muscles.

An expert explained the advantages and disadvantages of radiation as a treatment for patients with renal cell carcinoma, a type of kidney cancer.

The panel concludes with Danielle Hicks sharing where viewers can go to learn more about the information and resources discussed in the panel, including safety information. Sponsored by Bristol Myers Squibb.

Danielle Hicks, a patient advocate, details her journey as a caregiver for her mother and provides advice for other caring for loved ones with lung cancer. Sponsored by Bristol Myers Squibb.

Danielle Hicks, Nisha Mohindra, MD, and Christopher Towe, MD, share their perspectives and offer advice to those navigating an early-stage non-small cell lung cancer diagnosis. Sponsored by Bristol Myers Squibb.

Nisha Mohindra, MD, and Christopher Towe, MD, define the term “multidisciplinary team” and explain why early-stage NSCLC care requires a diverse group of specialists. They also discuss the function and value of this collaborative model in guiding treatment plans. Sponsored by Bristol Myers Squibb.

The panel shares insights on the progress in early-stage non-small cell lung cancer treatment and the potential role of neoadjuvant therapy. Sponsored by Bristol Myers Squibb.

Nisha Mohindra, MD, and Christopher Towe, MD, discuss what early-stage non-small cell lung cancer treatment options have looked like in the past and a more recent treatment option, neoadjuvant therapy. Sponsored by Bristol Myers Squibb.

After Danielle Hicks introduces the panelists, Nisha Mohindra, MD, and Christopher Towe, MD, provide an overview of what an early-stage non-small cell lung cancer diagnosis means and how it is diagnosed. Sponsored by Bristol Myers Squibb.

Panelists discuss how the landscape of treatment options for advanced prostate cancer has evolved, highlighting the importance of understanding current therapies to optimize patient outcomes.

Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding treatment decisions.